Sanofi (SNY) Non-Current Assets (2009 - 2026)

Sanofi has disclosed Non-Current Assets across 18 years of filings, most recently posting $114.6 billion for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $114.6 billion, up 23.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.6 billion (up 23.95% YoY), and the FY2025 annual result was $111.6 billion, up 15.75% from the prior year.
• Non-Current Assets came in at $114.6 billion for Q1 2026 at Sanofi, up from $111.6 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $114.6 billion in Q1 2026 to a low of $92.4 billion in Q1 2025.
• The 5-year median for Non-Current Assets is $103.1 billion (2023), against an average of $103.1 billion.
• Across the five-year window, Non-Current Assets declined 7.81% in 2022 and increased 23.95% in 2026, its largest moves.
• Sanofi's Non-Current Assets stood at $94.5 billion in 2022, then increased by 9.08% to $103.1 billion in 2023, then slipped by 6.47% to $96.4 billion in 2024, then gained by 15.75% to $111.6 billion in 2025, then increased by 2.68% to $114.6 billion in 2026.
• The last three Non-Current Assets figures came in at $114.6 billion (Q1 2026), $111.6 billion (Q4 2025), and $111.9 billion (Q3 2025), per Business Quant data.